Drägerwerk Financial Statements From 2010 to 2025
| DGWPF Stock | USD 72.00 0.00 0.00% |
Check Drägerwerk financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Drägerwerk's main balance sheet or income statement drivers, such as , as well as many indicators such as . Drägerwerk financial statements analysis is a perfect complement when working with Drägerwerk Valuation or Volatility modules.
Drägerwerk |
Drgerwerk AG Co Company Operating Margin Analysis
Drägerwerk's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Drägerwerk Operating Margin | (0.05) % |
Most of Drägerwerk's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Drgerwerk AG Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Drgerwerk AG Co has an Operating Margin of -0.0456%. This is 99.87% lower than that of the Healthcare sector and 99.88% lower than that of the Medical Devices industry. The operating margin for all United States stocks is 99.17% lower than that of the firm.
Drgerwerk AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Drägerwerk's current stock value. Our valuation model uses many indicators to compare Drägerwerk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Drägerwerk competition to find correlations between indicators driving Drägerwerk's intrinsic value. More Info.Drgerwerk AG Co is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Drägerwerk's earnings, one of the primary drivers of an investment's value.About Drägerwerk Financial Statements
Drägerwerk stakeholders use historical fundamental indicators, such as Drägerwerk's revenue or net income, to determine how well the company is positioned to perform in the future. Although Drägerwerk investors may analyze each financial statement separately, they are all interrelated. For example, changes in Drägerwerk's assets and liabilities are reflected in the revenues and expenses on Drägerwerk's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Drgerwerk AG Co. Please read more on our technical analysis and fundamental analysis pages.
KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. KGaA was founded in 1889 and is headquartered in Lbeck, Germany. Draegerwerk operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 16043 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Drägerwerk Pink Sheet
Drägerwerk financial ratios help investors to determine whether Drägerwerk Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drägerwerk with respect to the benefits of owning Drägerwerk security.